An Overview of Liver Directed Locoregional Therapies

Diederik J Höppener; Dirk J Grünhagen; Alexander M M Eggermont; Astrid A M van der Veldt; Cornelis Verhoef

doi:10.1016/j.soc.2020.09.001

An Overview of Liver Directed Locoregional Therapies

Diederik J Höppener, Dirk J Grünhagen, Alexander M M Eggermont, Astrid A M van der Veldt, Cornelis Verhoef^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

8 Citations (Scopus)

190 Downloads (Pure)

Abstract

An overview of all liver-directed locoregional therapies, including surgical resection for melanoma liver metastases (MLMs), is provided. MLM patients are divided by their primary melanoma location; cutaneous, uvea (eye), and mucosal melanoma. If patients with isolated cutaneous MLMs are considered for surgical resection, treatment with systemic therapy should be part of the treatment course. For uveal MLMs, complete surgical or ablative treatment of all MLMs suggests superior results compared with other liver-directed or systemic therapies, based on current evidence, no recommendations for any liver-directed regional therapy in the treatment of mucosal MLMs can be made.

Original language	English
Pages (from-to)	103-123
Number of pages	21
Journal	Surgical Oncology Clinics of North America
Volume	30
Issue number	1
DOIs	https://doi.org/10.1016/j.soc.2020.09.001
Publication status	Published - Jan 2021

Bibliographical note

Research programs

EMC OR-01

Access to Document

10.1016/j.soc.2020.09.001Licence: CC BY

An Overview of Liver Directed Locoregional TherapiesFinal published version, 1.09 MBLicence: CC BY

Cite this

@article{c8d24925140141be93d1136c909f0d1c,

title = "An Overview of Liver Directed Locoregional Therapies",

abstract = "An overview of all liver-directed locoregional therapies, including surgical resection for melanoma liver metastases (MLMs), is provided. MLM patients are divided by their primary melanoma location; cutaneous, uvea (eye), and mucosal melanoma. If patients with isolated cutaneous MLMs are considered for surgical resection, treatment with systemic therapy should be part of the treatment course. For uveal MLMs, complete surgical or ablative treatment of all MLMs suggests superior results compared with other liver-directed or systemic therapies, based on current evidence, no recommendations for any liver-directed regional therapy in the treatment of mucosal MLMs can be made.",

author = "H{\"o}ppener, {Diederik J} and Gr{\"u}nhagen, {Dirk J} and Eggermont, {Alexander M M} and {van der Veldt}, {Astrid A M} and Cornelis Verhoef",

year = "2021",

month = jan,

doi = "10.1016/j.soc.2020.09.001",

language = "English",

volume = "30",

pages = "103--123",

journal = "Surgical Oncology Clinics of North America",

issn = "1055-3207",

number = "1",

}

TY - JOUR

T1 - An Overview of Liver Directed Locoregional Therapies

AU - Höppener, Diederik J

AU - Grünhagen, Dirk J

AU - Eggermont, Alexander M M

AU - van der Veldt, Astrid A M

AU - Verhoef, Cornelis

PY - 2021/1

Y1 - 2021/1

N2 - An overview of all liver-directed locoregional therapies, including surgical resection for melanoma liver metastases (MLMs), is provided. MLM patients are divided by their primary melanoma location; cutaneous, uvea (eye), and mucosal melanoma. If patients with isolated cutaneous MLMs are considered for surgical resection, treatment with systemic therapy should be part of the treatment course. For uveal MLMs, complete surgical or ablative treatment of all MLMs suggests superior results compared with other liver-directed or systemic therapies, based on current evidence, no recommendations for any liver-directed regional therapy in the treatment of mucosal MLMs can be made.

AB - An overview of all liver-directed locoregional therapies, including surgical resection for melanoma liver metastases (MLMs), is provided. MLM patients are divided by their primary melanoma location; cutaneous, uvea (eye), and mucosal melanoma. If patients with isolated cutaneous MLMs are considered for surgical resection, treatment with systemic therapy should be part of the treatment course. For uveal MLMs, complete surgical or ablative treatment of all MLMs suggests superior results compared with other liver-directed or systemic therapies, based on current evidence, no recommendations for any liver-directed regional therapy in the treatment of mucosal MLMs can be made.

UR - http://www.scopus.com/inward/record.url?scp=85096500625&partnerID=8YFLogxK

U2 - 10.1016/j.soc.2020.09.001

DO - 10.1016/j.soc.2020.09.001

M3 - Article

C2 - 33220800

SN - 1055-3207

VL - 30

SP - 103

EP - 123

JO - Surgical Oncology Clinics of North America

JF - Surgical Oncology Clinics of North America

IS - 1

ER -

An Overview of Liver Directed Locoregional Therapies

Abstract

Bibliographical note

Research programs

Access to Document

Other files and links

Fingerprint

An Overview of Liver Directed Locoregional Therapies

Cite this